To learn more about the broader landscape of these compounds, you can visit a trusted peptide research lab
2020 Jan;33(1):e13192
Regulatory acceptance varies by region, with formal approval in certain therapeutic settings and off-label use prevalent in others under clinical supervision
The Watkinsville, Georgia biotech makes recombinant peptides, proteins, antibodies, and fibrils, including target classes like Beta-Amyloid, Tau, and Synuclein
Written by: OnePoint Patient Care Clinical Team Joseph Solien, PharmD, BCGP, BCPP Vice President of Clinical Services Melissa Corak, PharmD, BCGP Senior Clinical Pharmacist John Corrigan, PharmD, BCGP Clinical Pharmacist References Bartz L, Klein C, Seifert A, et al